What should I know about blood clot risk during HER2-Positive Breast Cancer treatment

Blood Clot Risk During HER2-Positive Breast Cancer Treatment

This is an important question, as blood clots (venous thromboembolism) are a recognized concern during cancer treatment. Let me explain what you should know.

Why Blood Clots Are a Concern During Cancer Treatment

Cancer itself increases clot risk because:

• Cancer cells release substances that activate the blood's clotting system
• Tumors can compress blood vessels, slowing blood flow
• Cancer treatment (especially chemotherapy) can damage blood vessel linings
• Reduced mobility during treatment increases clot risk

HER2-Targeted Therapy and Clot Risk

According to NCCN Guidelines for Invasive Breast Cancer, HER2-targeted therapies include:

• HER2 antibodies (like trastuzumab and pertuzumab) that block growth signals
• HER2 inhibitors that stop signals from within the cell
• HER2 antibody-drug conjugates (ADCs) like ado-trastuzumab emtansine that deliver chemotherapy directly to cancer cells

While the NCCN guidelines emphasize that heart function monitoring (LVEF testing) is critical during HER2-targeted therapy, the guidelines don't specifically highlight blood clots as a primary concern with these targeted agents themselves.

However, if your treatment includes chemotherapy combined with HER2-targeted therapy (which is common), chemotherapy does increase clot risk.

What You Should Monitor For

Signs of blood clots include:

• Swelling in one leg (usually calf or thigh)
• Warmth, redness, or tenderness in the leg
• Chest pain or shortness of breath
• Sudden difficulty breathing

Seek immediate medical attention if you experience these symptoms.

Questions to Ask Your Oncology Team

1. What is my specific clot risk based on my treatment plan, stage, and other health factors?
2. Will I need blood clot prevention medication (like anticoagulants or aspirin)?
3. What symptoms should I report immediately, and how do I contact you after hours?
4. Are there activity recommendations to reduce clot risk (like staying mobile, avoiding prolonged immobility)?
5. Should I wear compression stockings during treatment?

Important Preventive Steps

• Stay active: Movement helps prevent clots. Ask your team about safe exercise during treatment
• Stay hydrated: Drink plenty of water unless your doctor advises otherwise
• Avoid prolonged immobility: Don't sit or lie down for extended periods without moving
• Report symptoms early: Don't wait to see if symptoms resolve on their own
• Inform all your doctors: Make sure your primary care doctor knows about your cancer treatment

The Bigger Picture

According to the NCCN Guidelines, your care team will monitor you closely during HER2-targeted therapy, with particular attention to heart health. Blood clot risk assessment and prevention should be part of your overall treatment safety plan, even if it's not the primary focus.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your oncologist can assess your individual clot risk based on your complete medical picture and recommend specific prevention strategies tailored to your situation.